Loading clinical trials...
Loading clinical trials...
Randomized Controlled Phase II Clinical Trial on mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma Patients Who Are Disease-free Following the Local Treatment of Macrometastases.
Conditions
Interventions
Dendritic cell therapy
Locations
1
Belgium
UZ Brussel
Brussels, Belgium
Start Date
October 1, 2012
Primary Completion Date
September 1, 2015
Completion Date
September 1, 2016
Last Updated
May 24, 2017
NCT06794775
NCT03493230
NCT02977052
NCT03132090
NCT01983124
NCT00722098
Lead Sponsor
Universitair Ziekenhuis Brussel
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions